A revolutionary cancer treatment called belantamab mafodotin is now being offered by the NHS in a global first. This "Trojan ...

England is set to become the first health system globally to offer the "Trojan horse" therapy, belantamab mafodotin (Blenrep), developed by GSK, for patients with multiple myeloma, following its ...

The Centers for Disease Control and Prevention has announced that a tainted batch of pistachio cream has put at least one ...

Around 1,500 people with multiple myeloma will benefit from belantamab mafodotin, used in combination with bortezomib and ...